A Canadian order for smallpox vaccines worth DKK 195m (USD 31.3m) and continued speculation surrounding Bavarian Nordic's Covid-19 vaccine's glorious future has caused its share price to skyrocket in early Monday trading.
Following just over half an hour of trades, Bavarian increases further 9 percent to DKK 313.60 on top of the 36-percent appreciation from last week.
Already a subscriber? Log in.
Read the whole article
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.Start a free company trial today
Your trial for MedWatch has now started
With your free trial you get:
Full access to all locked articles on MedWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.